Company · CIK 1806310
Taysha Gene Therapies, Inc.
| CIK | 1806310 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | TX |
| Listed | TSHA (Nasdaq) |
| First annual or quarterly report | 2020-11-12 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291244 | 2025-11-04 | 2026-06-25 | 3 | |
| 333-283801 | 2024-12-13 | 2025-05-29 | 4 | |
| 333-260069 | 2021-10-05 | 2024-06-26 | 8 | |
| 333-274264 | 2023-08-30 | 2023-09-08 | 2 | |
| 333-271144 | 2023-04-05 | 2023-05-01 | 2 | |
| 333-248559 | 2020-09-02 | 2020-09-25 | 6 |
Filings
26| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-25 | 424B5Shelf takedown | 333-291244 | 0001193125-26-282846 |
| 2026-06-24 | 424B5Shelf takedown | 333-291244 | 0001193125-26-281288 |
| 2025-11-04 | S-3ASRShelf registered | 333-291244 | 0001193125-25-263634 |
| 2025-05-29 | 424B5Shelf takedown | 333-283801 | 0001193125-25-130693 |
| 2025-05-28 | 424B5Shelf takedown | 333-283801 | 0001193125-25-129569 |
| 2024-12-20 | EFFECTDeclared effective | 333-283801 | 9999999995-24-003902 |
| 2024-12-13 | S-3Shelf registered | 333-283801 | 0001193125-24-278466 |
| 2024-06-26 | 424B5Shelf takedown | 333-260069 | 0001193125-24-169188 |
| 2024-06-26 | 424B5Shelf takedown | 333-260069 | 0001193125-24-168470 |
| 2023-09-08 | EFFECTDeclared effective | 333-274264 | 9999999995-23-002613 |
| 2023-08-30 | S-3Shelf registered | 333-274264 | 0001193125-23-224918 |
| 2023-05-01 | EFFECTDeclared effective | 333-271144 | 9999999995-23-001202 |
| 2023-04-05 | S-3Shelf registered | 333-271144 | 0001193125-23-092350 |
| 2023-03-29 | 424B5Shelf takedown | 333-260069 | 0001193125-23-082441 |
| 2022-10-27 | 424B5Shelf takedown | 333-260069 | 0001193125-22-271102 |
| 2022-10-25 | 424B5Shelf takedown | 333-260069 | 0001193125-22-268409 |
| 2022-03-31 | 424B5Shelf takedown | 333-260069 | 0001193125-22-091855 |
| 2021-10-14 | EFFECTDeclared effective | 333-260069 | 9999999995-21-003891 |
| 2021-10-05 | S-3Shelf registered | 333-260069 | 0001193125-21-292221 |
| 2020-09-25 | 424B4Final prospectus | 333-248559 | 0001193125-20-253550 |
| 2020-09-23 | EFFECTDeclared effective | 333-248559 | 9999999995-20-002541 |
| 2020-09-18 | S-1/AAmendment | 333-248559 | 0001193125-20-248359 |
| 2020-09-17 | S-1/AAmendment | 333-248559 | 0001193125-20-247565 |
| 2020-09-08 | S-1/AAmendment | 333-248559 | 0001193125-20-241062 |
| 2020-09-02 | S-1Registration filed | 333-248559 | 0001193125-20-238197 |
| 2020-08-03 | DRSDraft made public | 377-03364 | 0000950123-20-007499 |